778 related articles for article (PubMed ID: 29743358)
1. Chromatin-Remodeling Factor SPOC1 Acts as a Cellular Restriction Factor against Human Cytomegalovirus by Repressing the Major Immediate Early Promoter.
Reichel A; Stilp AC; Scherer M; Reuter N; Lukassen S; Kasmapour B; Schreiner S; Cicin-Sain L; Winterpacht A; Stamminger T
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743358
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic Immune Mechanisms Restricting Human Cytomegalovirus Replication.
Schilling EM; Scherer M; Stamminger T
Viruses; 2021 Jan; 13(2):. PubMed ID: 33530304
[TBL] [Abstract][Full Text] [Related]
3. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
Ahn JH; Hayward GS
Virology; 2000 Aug; 274(1):39-55. PubMed ID: 10936087
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses.
Scherer M; Otto V; Stump JD; Klingl S; Müller R; Reuter N; Muller YA; Sticht H; Stamminger T
J Virol; 2016 Feb; 90(3):1190-205. PubMed ID: 26559840
[TBL] [Abstract][Full Text] [Related]
5. SPOC1-mediated antiviral host cell response is antagonized early in human adenovirus type 5 infection.
Schreiner S; Kinkley S; Bürck C; Mund A; Wimmer P; Schubert T; Groitl P; Will H; Dobner T
PLoS Pathog; 2013; 9(11):e1003775. PubMed ID: 24278021
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.
Tavalai N; Papior P; Rechter S; Leis M; Stamminger T
J Virol; 2006 Aug; 80(16):8006-18. PubMed ID: 16873257
[TBL] [Abstract][Full Text] [Related]
7. Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability.
Biolatti M; Dell'Oste V; Pautasso S; von Einem J; Marschall M; Plachter B; Gariglio M; De Andrea M; Landolfo S
J Virol; 2016 Sep; 90(18):8238-50. PubMed ID: 27384655
[TBL] [Abstract][Full Text] [Related]
8. Expression of Oncogenic Alleles Induces Multiple Blocks to Human Cytomegalovirus Infection.
Xu S; Schafer X; Munger J
J Virol; 2016 May; 90(9):4346-4356. PubMed ID: 26889030
[TBL] [Abstract][Full Text] [Related]
9. MORC3 restricts human cytomegalovirus infection by suppressing the major immediate-early promoter activity.
Ma XH; Yao YX; Wang XZ; Zhou YP; Huang SN; Li D; Mei MJ; Wu JP; Pan YT; Cheng S; Jiang X; Sun JY; Zeng WB; Gong S; Cheng H; Luo MH; Yang B
J Med Virol; 2022 Nov; 94(11):5492-5506. PubMed ID: 35879101
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Novel Antiviral Effect of the Restriction Factor SPOC1 against Human Cytomegalovirus.
Kuderna AK; Reichel A; Tillmanns J; Class M; Scherer M; Stamminger T
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543731
[TBL] [Abstract][Full Text] [Related]
11. The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.
Schilling EM; Scherer M; Reuter N; Schweininger J; Muller YA; Stamminger T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903803
[TBL] [Abstract][Full Text] [Related]
12. The Interferon-Inducible Human PLSCR1 Protein Is a Restriction Factor of Human Cytomegalovirus.
Sadanari H; Takemoto M; Ishida T; Otagiri H; Daikoku T; Murayama T; Kusano S
Microbiol Spectr; 2022 Feb; 10(1):e0134221. PubMed ID: 35138119
[TBL] [Abstract][Full Text] [Related]
13. CTCF binding to the first intron of the major immediate early (MIE) gene of human cytomegalovirus (HCMV) negatively regulates MIE gene expression and HCMV replication.
Martínez FP; Cruz R; Lu F; Plasschaert R; Deng Z; Rivera-Molina YA; Bartolomei MS; Lieberman PM; Tang Q
J Virol; 2014 Jul; 88(13):7389-401. PubMed ID: 24741094
[TBL] [Abstract][Full Text] [Related]
14. The downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 axis and by human cytomegalovirus (HCMV) associated factors allows the activation of the HCMV major IE promoter and the transition to productive infection.
Sourvinos G; Morou A; Sanidas I; Codruta I; Ezell SA; Doxaki C; Kampranis SC; Kottakis F; Tsichlis PN
PLoS Pathog; 2014 May; 10(5):e1004136. PubMed ID: 24830456
[TBL] [Abstract][Full Text] [Related]
15. The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters.
Lo Cigno I; De Andrea M; Borgogna C; Albertini S; Landini MM; Peretti A; Johnson KE; Chandran B; Landolfo S; Gariglio M
J Virol; 2015 Aug; 89(15):7506-20. PubMed ID: 25972554
[TBL] [Abstract][Full Text] [Related]
16. Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0.
Hou W; Cruz-Cosme R; Wen F; Ahn JH; Reeves I; Luo MH; Tang Q
J Virol; 2018 Dec; 92(23):. PubMed ID: 30258013
[TBL] [Abstract][Full Text] [Related]
17. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
18. RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.
Xiaofei E; Stadler BM; Debatis M; Wang S; Lu S; Kowalik TF
J Virol; 2012 May; 86(10):5660-73. PubMed ID: 22438545
[TBL] [Abstract][Full Text] [Related]
19. KAP1 Is a Host Restriction Factor That Promotes Human Adenovirus E1B-55K SUMO Modification.
Bürck C; Mund A; Berscheminski J; Kieweg L; Müncheberg S; Dobner T; Schreiner S
J Virol; 2016 Jan; 90(2):930-46. PubMed ID: 26537675
[TBL] [Abstract][Full Text] [Related]
20. The 5' Untranslated Region of the Major Immediate Early mRNA Is Necessary for Efficient Human Cytomegalovirus Replication.
Arend KC; Lenarcic EM; Moorman NJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]